The phrase "a decrease in seizure" is not correct in standard English usage.
It should be "a decrease in seizures" to refer to a reduction in the occurrence of seizures.
Example: "The new medication has resulted in a significant decrease in seizures for patients with epilepsy."
Alternatives: "a reduction in seizures" or "a decline in seizure frequency."
A decrease in seizure latency and an increase in seizure severity were also observed.
Tolerance manifested as a decrease in seizure threshold to near-control values, while withdrawal hyperexcitability was evidenced by a significant decrease in seizure threshold below the control value.
Nevertheless, a trend towards a decrease in seizure frequency and increase in responder rate during levetiracetam administration compared to placebo warrants further evaluation in a larger scale study.
Despite the high seizure frequency and cluster seizures, 67% of dogs had a decrease in seizure frequency by 50% or more.
The placebo effect is a well-known phenomenon and has been demonstrated, manifesting as a decrease in seizure frequency, in dogs with epilepsy.
In this series, in which we used resection exclusively, without MST, 49.1% of the patients experienced a postoperative seizure-free state; moreover, we observed a decrease in seizure frequency and intensity of 90.9%.
Once the full memantine dosage was achieved, there was a decrease in average seizure frequency to 3.3 per week (SEM = 0.3).
However, eight of the ten prospective studies did not perform a formal statistical evaluation, and only one of the other two studies found a significant decrease in seizure frequency in a subgroup analysis [ 12, 23– 31].
However, a dose of 150 μg/kg resulted in a significant decrease in seizure latency.
While CBZ was ineffective in all animals, VPA induced, during treatment, a progressive decrease in seizure frequency in animals primarily suffering from non-spreading neocortical seizures, but was ineffective in animals with a high frequency of spreading seizures.
A significant decrease in seizure frequency was reported compared with baseline, however, no difference was detected in seizure frequency when levetiractam was compared with placebo.
